What Scotts Miracle-Gro’s medical marijuana acquisition, MORE Act mean for you
A look at what Scotts Miracle-Gro’s involvement in the Etain Health acquisition and U.S. House passage of the MORE Act mean for the marijuana industry.
Ohio Medical Marijuana Business News
A look at what Scotts Miracle-Gro’s involvement in the Etain Health acquisition and U.S. House passage of the MORE Act mean for the marijuana industry.
Cresco Labs is expected to sell off $250 million-$500 million worth of marijuana cultivation and retail licenses largely to meet state license limits as part of its planned $2 billion acquisition of rival Columbia Care.
Everyone in the cannabis business has their eyes on the Northeast, and for good reason.
But cannabis multistate operators should think about setting their sights a bit farther west, to states such as Michigan, Missouri, Nebraska and Ohio.
Major multistate cannabis operators Cresco Labs and Columbia Care said Wednesday they have agreed to combine in a blockbuster deal worth roughly $2 billion, with Chicago-based Cresco set to acquire New York-headquartered Columbia.
California cannabis multistate operator Moxie sued the billionaire family backing insolvent Green Growth Brands, claiming fraud in connection with a $310 million merger deal in 2019 that was scrapped.
Ohio medical cannabis companies sold more than $381 million worth of MMJ in 2021, up about 72% from 2020.
FarmaceuticalRX, a medical cannabis producer with operations in Ohio and Pennsylvania, closed a $34 million loan from cannabis real estate financier Chicago Atlantic Real Estate Finance and other unspecified “institutional lenders.”